PanGen Biotech (222110) Stock Overview

PanGen Biotech Inc. operates as a specialized biologics company in South Korea. It develops biosimilar products, such as EPO, recombinant factor VIII, G-CSF, etc. The company also provides CHO cell lines for proteins and monoclonal antibodies; and one-stop services ranging from producer cell line development to GMP production. In addition, it offers reagents, quantitation kits, and cell based assay systems, as well as distributes polysciences products. PanGen Biotech Inc. was founded in 1999 and is based in Suwon-si, South Korea.